ADAS | Jotup

Applied Intuition, Inc. Grows to $6 Billion Valuation, Securing $250 Million in Series E Funding to Advance Vehicle Software and AI Capabilities

Retrieved on:

Tuesday, March 12, 2024

The round was led by Bilal Zuberi at Lux Capital (Series C lead investor), Elad Gil (Series D lead investor), and strategic investor Porsche Investments Management S.A.

Key Points:

The round was led by Bilal Zuberi at Lux Capital (Series C lead investor), Elad Gil (Series D lead investor), and strategic investor Porsche Investments Management S.A.
"Applied Intuition benefits from generational megatrends including generative AI, autonomous systems, and software-defined vehicles.
With recent advancements in large language models (LLMs), Applied Intuition is uniquely positioned to help its customers revolutionize the vehicle software development process.
"Our industry-leading vehicle software products will infuse AI technology to expand beyond our definitive ADAS and AD toolchain, which will exponentially accelerate the production of next-generation vehicles."

Applied Intuition, Inc. Grows to $6 Billion Valuation, Securing $250 Million in Series E Funding to Advance Vehicle Software and AI Capabilities

Retrieved on:

Tuesday, March 12, 2024

The round was led by Bilal Zuberi at Lux Capital (Series C lead investor), Elad Gil (Series D lead investor), and strategic investor Porsche Investments Management S.A.

Key Points:

The round was led by Bilal Zuberi at Lux Capital (Series C lead investor), Elad Gil (Series D lead investor), and strategic investor Porsche Investments Management S.A.
"Applied Intuition benefits from generational megatrends including generative AI, autonomous systems, and software-defined vehicles.
With recent advancements in large language models (LLMs), Applied Intuition is uniquely positioned to help its customers revolutionize the vehicle software development process.
"Our industry-leading vehicle software products will infuse AI technology to expand beyond our definitive ADAS and AD toolchain, which will exponentially accelerate the production of next-generation vehicles."

RoboSense Wins 2024 Tech.AD Award for Perception and Sensing

Retrieved on:

Monday, March 25, 2024

ROI, 2D, Original equipment manufacturer, Perception, Research, DNA, ADAS, CNAS, OEM, M3, Innovation system, Tech

STUTTGART, Germany, March 12, 2024 /PRNewswire/ -- RoboSense (2498.HK), a global leader in lidar and perception solutions, today announced that its long-range, automotive-grade M3 lidar sensor won the Tech.AD Europe Award 2024, which recognizes outstanding achievements in the automotive industry. RoboSense's M3 was honored in the Perception and Sensing category for its lidar innovation that is powering the future of intelligent vehicles.

Key Points:

STUTTGART, Germany, March 12, 2024 /PRNewswire/ -- RoboSense (2498.HK), a global leader in lidar and perception solutions, today announced that its long-range, automotive-grade M3 lidar sensor won the Tech.AD Europe Award 2024 , which recognizes outstanding achievements in the automotive industry.
RoboSense's M3 was honored in the Perception and Sensing category for its lidar innovation that is powering the future of intelligent vehicles.
The 2024 Tech.AD Europe award provides further validation that, with the M3, we are delivering on that promise, said Mingzhe Sun, Operations Director, RoboSense EMEA GmbH.
Representing RoboSense EMEA GmbH at Tech.AD and accepting this prestigious award are Gregory Poillion, Senior Sales Director , Felix Yang, Sales Director , and Mingzhe Sun, Operations Director.

Automotive Advanced Driver Assistance Systems: In-Depth Analysis of US OEMs' R&D Strategies Through 2030

Retrieved on:

Monday, March 11, 2024

ADAS, Original equipment manufacturer, Safety

DUBLIN, March 11, 2024 /PRNewswire/ -- The "US Passenger Vehicle Original Equipment Manufacturers Advanced Driver Assistance Systems R&D Strategies, 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points:

DUBLIN, March 11, 2024 /PRNewswire/ -- The "US Passenger Vehicle Original Equipment Manufacturers Advanced Driver Assistance Systems R&D Strategies, 2030" report has been added to ResearchAndMarkets.com's offering.
Growing demand for safety and convenience features has amplified the development and adoption of advanced driver assistance systems (ADAS) and autonomous driving (AD) features in passenger vehicles.
Original equipment manufacturers seek to adopt level-2-and-above features in their mass-market vehicles to gain a competitive advantage.
This study provides an overview of the ADAS and AD strategies that select global OEMs in the United States have adopted.

New Report Explores Privacy Implications of Driver Safety Systems

Retrieved on:

Tuesday, April 2, 2024

Well, FPF, Future of Privacy Forum, Bias, Location, ADAS, Policy, Disclosure, Privacy, Advanced driver-assistance system, Data collection, DMS, Safety, Vacuum, NHTSA, Government, Medical device

Report Offers Recommendations for Organizations Developing, Implementing, and Regulating Technologies Today, the Future of Privacy Forum (FPF) is releasing a new report explaining how safeguarding driver privacy and data protection will be critical to ensuring widespread acceptance of new safety technology in vehicles. This report comes as the National Highway Traffic Safety Administration (NHTSA) is [?]

Key Points:

Report Offers Recommendations for Organizations Developing, Implementing, and Regulating Technologies Today, the Future of Privacy Forum (FPF) is releasing a new report explaining how safeguarding driver privacy and data protection will be critical to ensuring widespread acceptance of new safety technology in vehicles. This report comes as the National Highway Traffic Safety Administration (NHTSA) is [?]

AI Stocks - Another Application to Watch; Transforming the Future of Transportation Safety

Retrieved on:

Monday, March 4, 2024

The Artificial Intelligence (AI) revolution is impacting all sectors, and transportation has not been left out.

Key Points:

The Artificial Intelligence (AI) revolution is impacting all sectors, and transportation has not been left out.
"AI is revolutionizing the transportation industry in many ways, and its impact on safety is significant.
This signifies a significant step forward in Rail Vision's commitment to advancing rail safety and efficiency through cutting-edge technologies.
Metropolis members can gain early access to NVIDIA platform updates to enhance their AI application development efforts.

Rail Vision Received Order from a Class 1 US Railroad Company for its AI-Based Safety System

Retrieved on:

Monday, March 11, 2024

Punctuality, Weather, RVSN, AI, Transport, ADAS, Safety, ODS, Machine learning, Accident, Rail transport

Ra’anana, Israel, March 11, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, today announced that it has received an order for its AI-driven Switch Yard System from a Class 1 freight rail company in the US.

Key Points:

Ra’anana, Israel, March 11, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, today announced that it has received an order for its AI-driven Switch Yard System from a Class 1 freight rail company in the US.
The freight rail company, which is one of the largest in North America, will install and use the system on its locomotive for evaluation and testing different scenarios related to safety.
"We believe that this new order is a milestone for Rail Vision that signifies the industry's trust in our solutions to navigate the complexities of rail operations.
This is another the beginning of our journey in North America to make rail transportation safer and more efficient for everyone", commented Rail Vision CEO, Shahar Hania.

BioVie Announces Pipeline Update and Near-Term Clinical Priorities

Retrieved on:

Monday, March 11, 2024

CARSON CITY, Nev., March 11, 2024 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that its recently completed funding round provides opportunity to further the Company’s clinical priorities in Parkinson’s Disease (PD), Alzheimer’s Disease (AD), and ascites/liver disease. The Company continues to explore longevity and aging in conjunction with external collaborators.

Key Points:

The Company continues to explore longevity and aging in conjunction with external collaborators.
The trial targets enrolling 100-150 patients in a 6-month trial with the Part 3 (motor) score on the MDS-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) as the primary endpoint.
Only one Phase 3 trial is potentially needed as BIV201 has already received Orphan and Fast Track designations.
BIV201 remains our most de-risked program, but it unfortunately is a program that will take two years to complete.

Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference

Retrieved on:

Friday, March 8, 2024

Central nervous system, Toxicity, Research, Pathology, ADAS, HGF, Hepatocyte growth factor, Conference, SHAPE, Doctor of Philosophy, Safety, Dementia, Survival, Athira Pharma, GBA1, Lewy body, Ageing, DSM-IV codes

BOTHELL, Wash., March 08, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, presented new clinical and preclinical data further highlighting the therapeutic potential of fosgonimeton at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, being held in Lisbon, Portugal March 5 – 9, 2024.

Key Points:

Fosgonimeton is a potentially first-in-class investigational small molecule designed to positively modulate the hepatocyte growth factor (HGF) system, which can activate neuroprotective, neurotrophic and anti-inflammatory pathways in the central nervous system.
“We believe safety and efficacy outcomes from the exploratory SHAPE Phase 2 clinical trial presented at this year’s AD/PD, along with previous clinical data, support the continued development of fosgonimeton.
These findings support the potential therapeutic benefit of modulating the neurotrophic HGF system with fosgonimeton for neurodegenerative diseases.
“We’re pleased to be presenting additional preclinical data highlighting the neuroprotective effects of fosgonimeton in models of both Alzheimer’s and Parkinson’s diseases at AD/PD 2024,” said Kevin Church, Ph.D., Chief Scientific Officer of Athira.

Commercial Vehicles Market cross $15.9 Tn by 2032, Says Global Market Insights Inc.

Retrieved on:

Wednesday, March 6, 2024

Scania AB, EV, Amazon Web Services, General Motors, USD, Transport, ADAS, Ford Motor Company, Urbanization, Toyota, BMW, Automation, Volvo, AWS

The commercial vehicles market valuation is estimated to reach USD 15.9 trillion by 2032, as reported in a research study by Global Market Insights Inc.

Key Points:

The commercial vehicles market valuation is estimated to reach USD 15.9 trillion by 2032, as reported in a research study by Global Market Insights Inc.
The commercial vehicles market from the construction & mining end-use segment is predicted to grow significantly through 2032, owing to the ongoing infrastructure development projects.
Increasing environmental concerns and stringent emissions regulations are driving the adoption of electric commercial vehicles, particularly in urban areas.
Asia Pacific commercial vehicles market will expand notably till 2032, driven by rapid urbanization, economic growth, and infrastructural development initiatives.